NASDAQ | TSX: ACB
Company Launches Internships at Manufacturing
Facility in Leuna, Germany to
Cultivate Future Leaders in the Medical Cannabis Industry
EDMONTON, AB, Jan. 10,
2025 /PRNewswire/ - Aurora Cannabis Inc.
(NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical
cannabis company, is pleased to announce the launch of an
internship program at Aurora's leading EU-GMP facility in Leuna,
Germany. In partnership with
Erfurt University of Applied Sciences,
students of the Horticultural Crop Production course will gain
valuable hands-on experience on-site and deepen their understanding
of medical cannabis cultivation. Aurora's investment in future
industry leaders is one of the many ways Aurora is expanding the
frontiers of global medical cannabis.
"We are thrilled to be giving these students the opportunity to
collaborate with our leading experts in the global medical cannabis
industry, providing them with unparalleled insights and skills,"
says Michael Simon, President of
Aurora Europe (Interim). "We are
committed to nurturing talent and fostering a collaborative
environment, ensuring that our interns leave with an enriched
understanding of the industry and a solid foundation for their
professional journeys."
Aurora's domestic cannabis facility located in Leuna,
Saxony-Anhalt, is one of the few sites in Germany permitted to grow medical cannabis.
The state-of-the-art indoor facility meets the highest standards of
operational excellence, using innovative and sustainable
cultivation methods, making it an ideal site for students to learn
best practices.
The six-month internship program will focus on all phases of
medical cannabis cultivation, including cloning, care, harvesting,
packaging and cleaning. Students will also participate in special
research and development projects.
Aurora's proven expertise in not only developing premium medical
cannabis products, but in cultivating great talent, both
domestically and globally, has allowed the company to maintain its
leadership position as the largest global medical cannabis company
operating in nationally legal markets.
About Aurora Cannabis Inc.
Aurora is opening the world to cannabis, serving both the
medical and consumer markets across Canada, Europe, Australia and South
America. Headquartered in Edmonton, Alberta, Aurora is a pioneer in
global cannabis, dedicated to helping people improve their lives.
The Company's adult-use brand portfolio includes Drift, San Rafael
'71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis
brands include MedReleaf, CanniMed, Aurora and Whistler Medical
Marijuana Co., as well as international brands, Pedanios, IndiMed
and CraftPlant. Aurora also has a controlling interest in Bevo
Farms Ltd., North America's
leading supplier of propagated agricultural plants. Driven by
science and innovation, and with a focus on high-quality cannabis
products, Aurora's brands continue to break through as industry
leaders in the medical, wellness and adult recreational markets
wherever they are launched. Learn more at
www.auroramj.com and follow us
on X and LinkedIn.
Aurora's common shares trade on the NASDAQ and TSX under the
symbol "ACB".
Forward Looking Information
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. Forward-looking statements made in this news
release include, but are not limited to, statements regarding the
Company's German internship partnership, the Company's expansion of
the frontiers of global medical cannabis and investment in future
industry leaders, and the Company's continued leadership position
as the largest global medical cannabis company operating in
nationally legal markets.
These forward-looking statements are only predictions. Forward
looking information or statements contained in this news release
have been developed based on assumptions management considers to be
reasonable. Material factors or assumptions involved in developing
forward-looking statements include, without limitation, publicly
available information from governmental sources as well as from
market research and industry analysis and on assumptions based on
data and knowledge of this industry which the Company believes to
be reasonable. Forward-looking statements are subject to a variety
of risks, uncertainties and other factors that management believes
to be relevant and reasonable in the circumstances could cause
actual events, results, level of activity, performance, prospects,
opportunities or achievements to differ materially from those
projected in the forward-looking statements. These risks include,
but are not limited to, the ability to retain key personnel, the
ability to continue investing in infrastructure to support growth,
the ability to obtain financing on acceptable terms, the continued
quality of our products, customer experience and retention, the
development of third party government and non-government consumer
sales channels, management's estimates of consumer demand in
Canada and in jurisdictions where
the Company exports, expectations of future results and expenses,
the risk of successful integration of acquired business and
operations (with respect to the Transaction and more generally with
respect to future acquisitions), management's estimation that
SG&A will grow only in proportion of revenue growth, the
ability to expand and maintain distribution capabilities, the
impact of competition, the general impact of financial market
conditions, the yield from cannabis growing operations, product
demand, changes in prices of required commodities, competition, and
the possibility for changes in laws, rules, and regulations in the
industry, epidemics, pandemics or other public health crises and
other risks, uncertainties and factors set out under the heading
"Risk Factors" in the Company's annual information from dated
June 20, 2024 (the "AIF") and filed
with Canadian securities regulators available on the Company's
issuer profile on SEDAR+ at www.sedarplus.com and filed with
and available on the SEC's website at www.sec.gov. The Company
cautions that the list of risks, uncertainties and other factors
described in the AIF is not exhaustive and other factors could also
adversely affect its results. Readers are urged to consider the
risks, uncertainties and assumptions carefully in evaluating the
forward-looking statements and are cautioned not to place undue
reliance on such information. The Company is under no obligation,
and expressly disclaims any intention or obligation, to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as expressly
required by applicable securities law.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/empowering-the-next-generation-aurora-announces-german-internship-program-302347597.html
SOURCE Aurora Cannabis Inc.